|
COPYRIGHT 2003 International Medical News Group
SNOWMASS, Cola. -- Thrombocytosis begins sooner in the course of Kawasaki disease than previously thought, so treatment should be initiated as early in the acute phase as possible, Dr. Rosie Scuccimarri said at an international conference on pediatric rheumatology sponsored by the American Academy of Pediatrics.
Along with intravenous immunoglobulin, low-dose acetylsalicylic acid appears to be equally effective as high-dose therapy at preventing complications from the platelet condition, according to the results of her...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
